{"url_path":"/sec/trlv/8-k/2026-07-02/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1754195/0001754195-26-000056-index.html","accession_number":"0001754195-26-000056","cik":"0001754195","ticker":"TRLV","issuer_name":"Trulieve Cannabis Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1754195/0001754195-26-000056-index.html","primary_entity_key":"0001754195","primary_entity_name":"Trulieve Cannabis Corp."},"word_count":465,"has_tables":true,"body_markdown":"tcnnf-20260630\nfalse000175419500017541952026-06-302026-06-30\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n____________________\n\nFORM 8-K\n\n___________________\n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d)\n\nof the Securities Exchange Act of 1934\n\nDate of Report (Date of Earliest Event Reported): June 30, 2026\n\n___________________\n\nTRULIEVE CANNABIS CORP.\n\n(Exact Name of Registrant as specified in its charter)\n\n___________________\n\nBritish Columbia000-5624884-2231905\n\n(State or Other Jurisdiction\n\nof Incorporation)\n\n(Commission\n\nFile Number)\n\n(IRS Employer\n\nIdentification No.)\n\n3494 Martin Hurst Road\nTallahassee, FL 32312\n(Address of principal executive offices and zip code)\n\n(850) 298-8866\n\n(Registrant’s telephone number, including area code)\n\nNot Applicable\n\n(Registrant’s name or former address, if change since last report)\n\n___________________\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\noWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\noSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\noPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\noPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\nTrading\n\nSymbol(s)\n\nName of each exchange\n\non which registered\n\nSubordinate Voting Shares, no par valueTRLVThe New York Stock Exchange LLC\n\nIndicate by check mark where the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\nEmerging Growth Company o\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o\n\n5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\nTermination of Brett Walsh as Chief Accounting Officer\n\nAs of June 30, 2026, Trulieve Cannabis Corp. (the “Company”) eliminated the stand-alone position of Chief Accounting Officer. In connection with this action, the Company terminated the employment of Mr. Walsh, who has served as the Company’s Chief Accounting Officer (principal accounting officer), without cause. The Company thanks Mr. Walsh for his leadership and service as Chief Accounting Officer and for his contributions to the Company’s finance organization.\n\nAppointment of Principal Accounting Officer\n\nIn connection with the elimination of the stand-alone position of Chief Accounting Officer, the Company appointed Jan Reese, the Company’s Chief Financial Officer (principal financial officer), as the Company’s principal accounting officer, effective June 30, 2026. Mr. Reese will not receive any adjustment to his compensation or any additional compensation in connection with performing the functions of the Company’s principal accounting officer."}